The concentrated buying, especially the $500K purchase by Hamilton Thomas Edward, suggests strong confidence in the company’s near-term prospects. Traders should monitor for upcoming catalysts such as clinical trial updates or regulatory filings.
LRMR drugs
LRMR drug pipeline →How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Feb 27 $5.31entry
- T+1 · 9mo ago −1.51%α −1.56% · $5.23
- T+5 · 9mo ago −1.69%α +0.29% · $5.22
- T+20 · 8mo ago −12.99%α −5.44% · $4.62
- T+60 · 6mo ago −34.65%α −44.04% · $3.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Three insiders at Larimar Therapeutics collectively purchased $550,000 worth of shares in open-market transactions on February 27, 2026, at $5 per share. The buyers include two individuals with similar names, Hamilton Thomas Edward and Thomas Frank E, possibly indicating a potential naming overlap, though both are reported as separate transactions.
Key Financial Metrics
Key Facts
- Three insiders purchased a total of 110,000 shares in open-market transactions on the same day (2026-02-27).
- Total value of purchases: $550,000.
- All transactions were open-market buys (Form 4 code 'P') at $5 per share.
- Hamilton Thomas Edward accounted for $500,000 of the total, representing 91% of the cluster value.
- Market cap of LRMR is $454M; total insider buying represents approximately 0.12% of market cap.
Financial Impact
$550,000 in open-market purchases, or 0.12% of market cap
Risk Factors
- The name 'Hamilton Thomas Edward' and 'Thomas Frank E' may indicate a data reporting anomaly or duplication, which could affect the perceived significance of the cluster.
- The total dollar amount, while notable, is still below 0.5% of market cap, limiting its macro impact.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CONTEXT: Insider Cluster Data (3 trades, 7d window) | cluster-LRMR-1772487080383 |
Track record
13 reports on LRMR
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today SC 13G Neutral 4/10 Entry $3.00 Now $3.00 0.00% settles Feb 12
- Nov 16, 2026today Press Release Bullish 7/10 Entry $3.10 Now $3.00 −3.23% settles Feb 12
- Nov 12, 20264d ago Insider Cluster Bullish 4/10 Entry $3.02 Now $3.00 −0.66% settles Feb 11
- Nov 9, 20267d ago 8-K Bullish 7/10 Entry $2.69 Now $3.00 +11.52% settles Feb 8
- Nov 5, 202611d ago Press Release Neutral 2/10 Entry $2.39 Now $3.00 +25.52% settles Feb 4
- Sep 29, 20266w ago Press Release Neutral 3/10 Entry $3.20 Now $3.00 −6.10% settles Dec 24
- Sep 22, 20267w ago Institutional Cluster Bearish 4/10 Entry $3.82 Now $3.00 +21.47% settles Dec 16
- May 14, 202626w ago 8-K Bullish 7/10 No price data
- May 14, 202626w ago Press Release Bullish 7/10 Entry $3.89 to $4.01 Now $3.00 −22.88% ▲ +3.08% −0.50% vs SPY
- Mar 19, 202634w ago Press Release Mixed 7/10 Entry $4.47 to $3.59 Now $3.00 −32.89% ▼ −19.69% −34.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers